222 related articles for article (PubMed ID: 33498739)
1. Effective Prediction of Prostate Cancer Recurrence through the
Gu Y; Lin X; Kapoor A; Li T; Major P; Tang D
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498739
[TBL] [Abstract][Full Text] [Related]
2. Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel Towards Prostate Cancer Relapse.
Gu Y; Chow MJ; Kapoor A; Lin X; Mei W; Tang D
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33578925
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression.
Lin X; Gu Y; Kapoor A; Wei F; Aziz T; Ojo D; Jiang Y; Bonert M; Shayegan B; Yang H; Al-Nedawi K; Major P; Tang D
Neoplasia; 2017 Nov; 19(11):857-867. PubMed ID: 28930697
[TBL] [Abstract][Full Text] [Related]
4. Construction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence.
Jiang Y; Mei W; Gu Y; Lin X; He L; Zeng H; Wei F; Wan X; Yang H; Major P; Tang D
Mol Oncol; 2018 Sep; 12(9):1559-1578. PubMed ID: 30024105
[TBL] [Abstract][Full Text] [Related]
5. Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development.
Gu Y; Chow MJ; Kapoor A; Mei W; Jiang Y; Yan J; De Melo J; Seliman M; Yang H; Cutz JC; Bonert M; Major P; Tang D
Transl Oncol; 2018 Aug; 11(4):1012-1022. PubMed ID: 29966864
[TBL] [Abstract][Full Text] [Related]
6. FAM84B promotes prostate tumorigenesis through a network alteration.
Jiang Y; Lin X; Kapoor A; He L; Wei F; Gu Y; Mei W; Zhao K; Yang H; Tang D
Ther Adv Med Oncol; 2019; 11():1758835919846372. PubMed ID: 31205500
[TBL] [Abstract][Full Text] [Related]
7. Construction of a Novel Multigene Panel Potently Predicting Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma.
Lin X; Kapoor A; Gu Y; Chow MJ; Peng J; Major P; Tang D
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33266355
[TBL] [Abstract][Full Text] [Related]
8. IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms.
Mei W; Dong Y; Gu Y; Kapoor A; Lin X; Su Y; Vega Neira S; Tang D
J Adv Res; 2023 Dec; 54():195-210. PubMed ID: 36681115
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of IQGAP2 Correlates with Prostate Cancer Recurrence and Metastasis.
Xie Y; Zheng L; Tao L
Transl Oncol; 2019 Feb; 12(2):236-244. PubMed ID: 30428404
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
Miller ET; You S; Cadaneanu RM; Kim M; Yoon J; Liu ST; Li X; Kwan L; Hodge J; Quist MJ; Grasso CS; Lewis MS; Knudsen BS; Freeman MR; Garraway IP
BMC Cancer; 2020 May; 20(1):398. PubMed ID: 32380981
[TBL] [Abstract][Full Text] [Related]
11. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
[TBL] [Abstract][Full Text] [Related]
12. Cdc20/p55 mediates the resistance to docetaxel in castration-resistant prostate cancer in a Bim-dependent manner.
Wu F; Lin Y; Cui P; Li H; Zhang L; Sun Z; Huang S; Li S; Huang S; Zhao Q; Liu Q
Cancer Chemother Pharmacol; 2018 Jun; 81(6):999-1006. PubMed ID: 29605876
[TBL] [Abstract][Full Text] [Related]
13. B7-H3 as a Therapeutic Target in Advanced Prostate Cancer.
Guo C; Figueiredo I; Gurel B; Neeb A; Seed G; Crespo M; Carreira S; Rekowski J; Buroni L; Welti J; Bogdan D; Gallagher L; Sharp A; Fenor de la Maza MD; Rescigno P; Westaby D; Chandran K; Riisnaes R; Ferreira A; Miranda S; Calì B; Alimonti A; Bressan S; Nguyen AHT; Shen MM; Hawley JE; Obradovic A; Drake CG; Bertan C; Baker C; Tunariu N; Yuan W; de Bono JS
Eur Urol; 2023 Mar; 83(3):224-238. PubMed ID: 36114082
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer.
Gong Y; Chippada-Venkata UD; Galsky MD; Huang J; Oh WK
Prostate; 2015 May; 75(6):616-27. PubMed ID: 25560638
[TBL] [Abstract][Full Text] [Related]
15. Diet-induced hypercholesterolemia promotes androgen-independent prostate cancer metastasis via IQGAP1 and caveolin-1.
Moon H; Ruelcke JE; Choi E; Sharpe LJ; Nassar ZD; Bielefeldt-Ohmann H; Parat MO; Shah A; Francois M; Inder KL; Brown AJ; Russell PJ; Parton RG; Hill MM
Oncotarget; 2015 Apr; 6(10):7438-53. PubMed ID: 25924234
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer.
Yun SJ; Kim SK; Kim J; Cha EJ; Kim JS; Kim SJ; Ha YS; Kim YH; Jeong P; Kang HW; Kim JH; Park JL; Choi YK; Moon SK; Choi YH; Kim SY; Kim WJ
Oncotarget; 2017 Dec; 8(70):114845-114855. PubMed ID: 29383125
[TBL] [Abstract][Full Text] [Related]
17. Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.
Winter JM; Curry NL; Gildea DM; Williams KA; Lee M; Hu Y; Crawford NPS
BMC Genomics; 2018 Jun; 19(1):450. PubMed ID: 29890952
[TBL] [Abstract][Full Text] [Related]
18. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.
Sackmann Sala L; Boutillon F; Menara G; De Goyon-Pélard A; Leprévost M; Codzamanian J; Lister N; Pencik J; Clark A; Cagnard N; Bole-Feysot C; Moriggl R; Risbridger GP; Taylor RA; Kenner L; Guidotti JE; Goffin V
J Pathol; 2017 Sep; 243(1):51-64. PubMed ID: 28603917
[TBL] [Abstract][Full Text] [Related]
19. Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression.
Sugie S; Mukai S; Yamasaki K; Kamibeppu T; Tsukino H; Kamoto T
Cancer Genomics Proteomics; 2015; 12(6):391-6. PubMed ID: 26543085
[TBL] [Abstract][Full Text] [Related]
20. RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer.
Linder A; Larsson K; Welén K; Damber JE
Prostate; 2020 Aug; 80(11):799-810. PubMed ID: 32449815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
